title: Taxanes in hormone-refractory prostate cancer.
authors.affiliation: Medicine Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
authors.forename: M H
authors.initials: MH
authors.lastname: Kang
authors.forename: W D
authors.initials: WD
authors.lastname: Figg
authors.forename: W
authors.initials: W
authors.lastname: Dahut
mesh_terms: D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use; D000972:Antineoplastic Agents, Phytogenic / Q000627:therapeutic use*; D000077143:Docetaxel; D019008:Drug Resistance, Neoplasm; D004961:Estramustine / Q000627:therapeutic use; D006728:Hormones / Q000627:therapeutic use; D006801:Humans; D008297:Male; D017239:Paclitaxel / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D011471:Prostatic Neoplasms / Q000188:drug therapy*; D043823:Taxoids; D016896:Treatment Outcome
chemical_list: D018931:Antineoplastic Agents, Hormonal; D000972:Antineoplastic Agents, Phytogenic; D006728:Hormones; D043823:Taxoids; D000077143:Docetaxel; D004961:Estramustine; D017239:Paclitaxel